5 Key Takeaways
-
1
Combining iStent Infinite with cataract surgery significantly lowers intraocular pressure (IOP) in glaucoma patients.
-
2
The addition of iDose TR further enhances IOP reduction and increases the number of patients achieving medication-free status.
-
3
Topical medications often fail to effectively manage glaucoma due to compliance issues and side effects.
-
4
Both surgical approaches resulted in significant reductions in IOP and the need for topical IOP-lowering medications.
-
5
The study highlights a proactive approach to glaucoma management that can improve patient quality of life.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.